Ginolis, a manufacturer of diagnostic disposables, plans to acquire JOT Automation’s Life Science Division, the companies recently announced. The merger is scheduled to take place during the first half of this year.
“The transaction is a win-win for both companies’ customers. It enables us to grow even more customer-centric and accelerates our time-to-market in our core business,” said Mika Kettula, CEO at JOT Automation, which supplies test and production solutions.
“JOT has successfully grown its customer base. Our customers now include many of the world’s leading consumer electronics companies. We are focusing our efforts on strengthening our test and precision assembly portfolios for the telecom industry, and Ginolis is better positioned to serve global life science clients.”
Teijo Fabritius, CEO at Ginolis said: “Our vision is to provide more effective healthcare for the benefit of patients globally by introducing unique solutions to the diagnostic, life science and medtech industries.
“By complementing our offering with JOT’s life science product range, we come closer to achieving our goal. We aim to be one of the largest suppliers of assembly automation for point-of-care tests and micro-fabricated components and products used in the medtech and diagnostics industry.”
In connection with the transaction, JOT Automation’s ownership of Ginolis will increase.